Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Learn how wealth creation through diversified investments can maximize your returns. Build a strong financial future now.
25,092 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Three utility ETFs are posting eye-catching gains as data-center demand grows, underscoring a new growth era for the ...
The latest CBO outlook warns the OASI trust fund could run dry by 2032 if reforms stall, signaling potential changes ...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
Midday trading shows inflation fears and global tensions pressing equities. This update breaks down what’s moving the...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
What if FI isn’t a distant dream for the ultra-rich? This story shows how disciplined saving, smart loans, and steady...
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...
ServiceNow stock falling today captures a moment of fear about AI disruption and rising expectations. This article br...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
When bond yields spiking higher, stock prices can face pressure, especially for growth-focused names. This guide brea...
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...